Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1488044863;44864;44865 chr2:178624642;178624641;178624640chr2:179489369;179489368;179489367
N2AB1323939940;39941;39942 chr2:178624642;178624641;178624640chr2:179489369;179489368;179489367
N2A1231237159;37160;37161 chr2:178624642;178624641;178624640chr2:179489369;179489368;179489367
N2B581517668;17669;17670 chr2:178624642;178624641;178624640chr2:179489369;179489368;179489367
Novex-1594018043;18044;18045 chr2:178624642;178624641;178624640chr2:179489369;179489368;179489367
Novex-2600718244;18245;18246 chr2:178624642;178624641;178624640chr2:179489369;179489368;179489367
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: N
  • RefSeq wild type transcript codon: AAT
  • RefSeq wild type template codon: TTA
  • Domain: Ig-100
  • Domain position: 28
  • Structural Position: 43
  • Q(SASA): 0.9235
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
N/S rs747496717 0.283 0.822 N 0.551 0.201 0.236278675362 gnomAD-2.1.1 4.03E-06 None None None None N None 0 0 None 0 0 None 0 None 0 0 1.66168E-04
N/S rs747496717 0.283 0.822 N 0.551 0.201 0.236278675362 gnomAD-4.0.0 1.59382E-06 None None None None N None 0 0 None 0 0 None 0 2.41896E-04 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
N/A 0.4888 ambiguous 0.4401 ambiguous -0.112 Destabilizing 0.754 D 0.62 neutral None None None None N
N/C 0.7838 likely_pathogenic 0.7535 pathogenic 0.264 Stabilizing 0.998 D 0.716 prob.delet. None None None None N
N/D 0.2021 likely_benign 0.1705 benign 0.132 Stabilizing 0.822 D 0.558 neutral N 0.481511927 None None N
N/E 0.5306 ambiguous 0.4817 ambiguous 0.076 Stabilizing 0.86 D 0.548 neutral None None None None N
N/F 0.7721 likely_pathogenic 0.7266 pathogenic -0.648 Destabilizing 0.993 D 0.671 neutral None None None None N
N/G 0.4676 ambiguous 0.4283 ambiguous -0.229 Destabilizing 0.019 N 0.273 neutral None None None None N
N/H 0.2389 likely_benign 0.2167 benign -0.26 Destabilizing 0.99 D 0.535 neutral D 0.550424452 None None N
N/I 0.5954 likely_pathogenic 0.499 ambiguous 0.098 Stabilizing 0.99 D 0.676 prob.neutral N 0.502632639 None None N
N/K 0.4076 ambiguous 0.3673 ambiguous 0.141 Stabilizing 0.058 N 0.325 neutral N 0.48369311 None None N
N/L 0.5104 ambiguous 0.4655 ambiguous 0.098 Stabilizing 0.978 D 0.641 neutral None None None None N
N/M 0.5416 ambiguous 0.496 ambiguous 0.21 Stabilizing 0.998 D 0.676 prob.neutral None None None None N
N/P 0.889 likely_pathogenic 0.8299 pathogenic 0.053 Stabilizing 0.993 D 0.665 neutral None None None None N
N/Q 0.5388 ambiguous 0.5129 ambiguous -0.206 Destabilizing 0.956 D 0.537 neutral None None None None N
N/R 0.6088 likely_pathogenic 0.5566 ambiguous 0.199 Stabilizing 0.915 D 0.513 neutral None None None None N
N/S 0.2221 likely_benign 0.1943 benign 0.02 Stabilizing 0.822 D 0.551 neutral N 0.476477603 None None N
N/T 0.2877 likely_benign 0.2408 benign 0.084 Stabilizing 0.904 D 0.528 neutral N 0.497345096 None None N
N/V 0.591 likely_pathogenic 0.5134 ambiguous 0.053 Stabilizing 0.978 D 0.674 neutral None None None None N
N/W 0.9298 likely_pathogenic 0.9035 pathogenic -0.748 Destabilizing 0.998 D 0.715 prob.delet. None None None None N
N/Y 0.3228 likely_benign 0.2795 benign -0.432 Destabilizing 0.99 D 0.662 neutral D 0.536602571 None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.